Robert F. Kennedy Jr.

And then something happened to NIH and a whole bunch of, there was a lot of corporate capture, all these mechanisms of corporate capture. But most importantly, in 1980, the Buy Dole Act was passed. And that act gave NIH and NIH individual scientists the rights to collect royalties on any drug that they worked on.

And then something happened to NIH and a whole bunch of, there was a lot of corporate capture, all these mechanisms of corporate capture. But most importantly, in 1980, the Buy Dole Act was passed. And that act gave NIH and NIH individual scientists the rights to collect royalties on any drug that they worked on.

And then something happened to NIH and a whole bunch of, there was a lot of corporate capture, all these mechanisms of corporate capture. But most importantly, in 1980, the Buy Dole Act was passed. And that act gave NIH and NIH individual scientists the rights to collect royalties on any drug that they worked on.

So, for example, today, the Moderna vaccine was produced by NIH and it's made tens of billions of dollars. Well, half that money will go to NIH.

So, for example, today, the Moderna vaccine was produced by NIH and it's made tens of billions of dollars. Well, half that money will go to NIH.

So, for example, today, the Moderna vaccine was produced by NIH and it's made tens of billions of dollars. Well, half that money will go to NIH.

And some of that money goes to scientists who work at NIH. There's six scientists who get to collect one hundred and fifty thousand dollars a year forever. Well, of course, if you have those kind of perverse economic incentives and conflicts of interest, it is going to subsume the regulatory function.

And some of that money goes to scientists who work at NIH. There's six scientists who get to collect one hundred and fifty thousand dollars a year forever. Well, of course, if you have those kind of perverse economic incentives and conflicts of interest, it is going to subsume the regulatory function.

And some of that money goes to scientists who work at NIH. There's six scientists who get to collect one hundred and fifty thousand dollars a year forever. Well, of course, if you have those kind of perverse economic incentives and conflicts of interest, it is going to subsume the regulatory function.

And beneath the kind of mercantile ambitions of those individuals who can make a lot of money, if you're paying for your boat and your alimony and your house and your children's education, a drug that you're supposed to be regulating, you may turn a blind eye. some of the problems with that drug, and you may do everything you can to get it through the regulatory process and get it mandated.

And beneath the kind of mercantile ambitions of those individuals who can make a lot of money, if you're paying for your boat and your alimony and your house and your children's education, a drug that you're supposed to be regulating, you may turn a blind eye. some of the problems with that drug, and you may do everything you can to get it through the regulatory process and get it mandated.

And beneath the kind of mercantile ambitions of those individuals who can make a lot of money, if you're paying for your boat and your alimony and your house and your children's education, a drug that you're supposed to be regulating, you may turn a blind eye. some of the problems with that drug, and you may do everything you can to get it through the regulatory process and get it mandated.

And that's what's happened. But not only that, the entire function of NIH has changed so that I think it was 2016 or 2017 when I actually did this calculation that was 220 new drugs approved by FDA, and all of them had come from NIH. So NIH is now the biggest incubator of pharmaceutical products.

And that's what's happened. But not only that, the entire function of NIH has changed so that I think it was 2016 or 2017 when I actually did this calculation that was 220 new drugs approved by FDA, and all of them had come from NIH. So NIH is now the biggest incubator of pharmaceutical products.

And that's what's happened. But not only that, the entire function of NIH has changed so that I think it was 2016 or 2017 when I actually did this calculation that was 220 new drugs approved by FDA, and all of them had come from NIH. So NIH is now the biggest incubator of pharmaceutical products.

And what's happened is they're no longer doing what they're supposed to be doing, which is to answer the question, why do we have an autism epidemic? Why do we have an obesity epidemic? It's pretty easy to figure out. There's only a certain number of suspects. You have processed foods, the PFOAs. You have neonicotinoid pesticides, atrazine, glyphosate, cell phone radiation.

And what's happened is they're no longer doing what they're supposed to be doing, which is to answer the question, why do we have an autism epidemic? Why do we have an obesity epidemic? It's pretty easy to figure out. There's only a certain number of suspects. You have processed foods, the PFOAs. You have neonicotinoid pesticides, atrazine, glyphosate, cell phone radiation.

And what's happened is they're no longer doing what they're supposed to be doing, which is to answer the question, why do we have an autism epidemic? Why do we have an obesity epidemic? It's pretty easy to figure out. There's only a certain number of suspects. You have processed foods, the PFOAs. You have neonicotinoid pesticides, atrazine, glyphosate, cell phone radiation.

There's a limited universe, and you can figure out pretty easily which ones are causing which effects, and it's probably cumulative, so they're all probably working on similar biological pathways and hurting our kids. You can figure out that too. NIH does not do that science.

There's a limited universe, and you can figure out pretty easily which ones are causing which effects, and it's probably cumulative, so they're all probably working on similar biological pathways and hurting our kids. You can figure out that too. NIH does not do that science.